Intravenous Plasma Treatment for Parkinson's Disease

Summary

This study will do a preliminary evaluation of a possible treatment for mild-to-moderate Parkinson's disease. Patients will be treated with either transfusions of plasma from young donors. or with placebo transfusions. In the following several months, Parkinson's symptoms will be monitored and compared for the two groups.

Timeline

Start

2018-09-24

Primary completion

2019-08-07

Completion

2019-08-08

Drugs

Indications